Norepinephrine use in cardiogenic shock patients is associated with increased 30 day mortality

AIMS: Norepinephrine is recommended as a first‐line vasopressor agent in the haemodynamic stabilization of cardiogenic shock. The survival benefit of norepinephrine therapy has not been demonstrated in clinical practice, however. This study aimed to explore the relationship between norepinephrine us...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xin, Wang, Xue, Gao, Yanxia, Walline, Joseph Harold, Yu, Shiyuan, Ge, Zengzheng, Qin, Mubing, Zhu, Huadong, Li, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065839/
https://www.ncbi.nlm.nih.gov/pubmed/35289504
http://dx.doi.org/10.1002/ehf2.13893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065839/
https://www.ncbi.nlm.nih.gov/pubmed/35289504
http://dx.doi.org/10.1002/ehf2.13893

Ejemplares similares